Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.
College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Mycoses. 2020 Apr;63(4):407-415. doi: 10.1111/myc.13058. Epub 2020 Feb 18.
Colletotrichum is a rare cause of human infection. Previous reports about Colletotrichum keratitis were limited, and most diagnoses from past reports were based on morphological distinction, which could have led to underestimation of the prevalence of Colletotrichum species.
We reported phylogenetic analysis, clinical feature and treatment outcome of molecularly diagnosed Colletotrichum keratitis in our hospital.
PATIENTS/METHODS: We recruited 65 patients with culture-proven filamentous fungal keratitis between January 1, 2015 and December 30, 2018. Through molecular sequencing including internal transcribed spacer (ITS) and multi-locus phylogenetic analysis of fungal DNA, seven patients were verified as infected with Colletotrichum species, and their medical records were reviewed to determine the clinical characteristics.
Six of seven patients had predisposing factors including trauma (5) and immunosuppressive status (1). Six isolates were initially misidentified as other fungi through morphological identification. ITS sequencing identified the isolates belonged to two species complex (SC): C. truncatum and C. gloeosporioides; multi-locus phylogenetic analysis enabled species identification including C. tropicale (3), C. fructicola (2), C. truncatum (1) and C. fusiforme (1). Five patients with C. gloeosporioides SC responded well to medical treatment and two patients with C truncatum SC underwent evisceration because of either no visual potential or intractable pain.
The molecular approach provides accurate diagnosis and raises epidemiological awareness of Colletotrichum keratitis. Through multi-locus phylogenetic analysis, we report the human infections caused by C. tropicale, C. fructicola and C. fusiforme. We also highlight the different clinical outcomes between C. gloeosporioides SC and C. truncatum SC.
炭疽菌是一种罕见的人类感染病原体。以前关于炭疽菌角膜炎的报告有限,过去大多数诊断报告都是基于形态学区别,这可能导致炭疽菌属的流行率被低估。
我们报告了我院经分子诊断的炭疽菌角膜炎的系统发育分析、临床特征和治疗结果。
患者/方法:我们招募了 2015 年 1 月 1 日至 2018 年 12 月 30 日期间经培养证实的 65 例丝状真菌角膜炎患者。通过包括内部转录间隔区(ITS)在内的分子测序和真菌 DNA 的多基因系统发育分析,7 例患者被证实感染了炭疽菌属,回顾了他们的病历以确定临床特征。
7 例患者中有 6 例存在潜在因素,包括外伤(5 例)和免疫抑制状态(1 例)。6 株分离株最初通过形态学鉴定被错误鉴定为其他真菌。ITS 测序鉴定这些分离株属于两个种复合体(SC):炭疽菌和胶孢炭疽菌;多基因系统发育分析能够鉴定出包括炭疽菌热带亚种(3 株)、炭疽菌果实炭疽亚种(2 株)、炭疽菌(1 株)和炭疽菌梭孢亚种(1 株)。5 例胶孢炭疽菌 SC 患者对药物治疗反应良好,2 例炭疽菌 SC 患者因无视力潜力或难治性疼痛而行眼内容剜除术。
分子方法提供了准确的诊断,并提高了对炭疽菌角膜炎的流行病学认识。通过多基因系统发育分析,我们报告了由炭疽菌热带亚种、炭疽菌果实炭疽亚种和炭疽菌梭孢亚种引起的人类感染。我们还强调了胶孢炭疽菌 SC 和炭疽菌 SC 之间不同的临床结果。